Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study
Clinical trial NCT05697705 · COMPLETED
Trial details
- NCT number
- NCT05697705
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-22
- Primary completion
- 2023-05-18
- Enrollment
- 188814085
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.